

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.45506363 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.45506363 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.14066597 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.14066597 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.80680052 |
| 6 | vitamin A metabolic process (GO:0006776) | 6.30230137 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.23468166 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.23468166 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.23468166 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.14456071 |
| 11 | kynurenine metabolic process (GO:0070189) | 6.06650002 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.89330821 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.84004240 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.83721674 |
| 15 | omega-hydroxylase P450 pathway (GO:0097267) | 5.55770565 |
| 16 | cysteine metabolic process (GO:0006534) | 5.55110615 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.52963898 |
| 18 | urea metabolic process (GO:0019627) | 5.46171465 |
| 19 | urea cycle (GO:0000050) | 5.46171465 |
| 20 | exogenous drug catabolic process (GO:0042738) | 5.44341483 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.39894315 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.34134889 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.31796205 |
| 24 | glial cell proliferation (GO:0014009) | 5.29440300 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.27273733 |
| 26 | regulation of protein activation cascade (GO:2000257) | 5.23027668 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.17856834 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.17174612 |
| 29 | protein carboxylation (GO:0018214) | 5.17174612 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.09941327 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.02509128 |
| 32 | response to mercury ion (GO:0046689) | 5.01350531 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.01156525 |
| 34 | bile acid metabolic process (GO:0008206) | 4.97107604 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.96706302 |
| 36 | regulation of complement activation (GO:0030449) | 4.90281176 |
| 37 | lysine metabolic process (GO:0006553) | 4.88128300 |
| 38 | lysine catabolic process (GO:0006554) | 4.88128300 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.78853413 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.75680388 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.74094205 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.73288261 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.68276424 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.66273998 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.63905561 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.63905561 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.63905561 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.62560301 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.48146104 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.48146104 |
| 51 | negative regulation of sterol transport (GO:0032372) | 4.45327599 |
| 52 | negative regulation of cholesterol transport (GO:0032375) | 4.45327599 |
| 53 | phospholipid efflux (GO:0033700) | 4.42748901 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 4.42381486 |
| 55 | cellular ketone body metabolic process (GO:0046950) | 4.42354315 |
| 56 | glutamate metabolic process (GO:0006536) | 4.34012392 |
| 57 | drug metabolic process (GO:0017144) | 4.33846411 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.31524872 |
| 59 | amine catabolic process (GO:0009310) | 4.30441974 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 4.30441974 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 4.28236249 |
| 62 | glycine metabolic process (GO:0006544) | 4.26810259 |
| 63 | * gamma-aminobutyric acid transport (GO:0015812) | 4.23554810 |
| 64 | histone H3-K9 demethylation (GO:0033169) | 4.22056660 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.21188117 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 4.20946151 |
| 67 | coenzyme catabolic process (GO:0009109) | 4.19124264 |
| 68 | cellular modified amino acid catabolic process (GO:0042219) | 4.16256000 |
| 69 | benzene-containing compound metabolic process (GO:0042537) | 4.13867886 |
| 70 | imidazole-containing compound metabolic process (GO:0052803) | 4.13157815 |
| 71 | ethanol oxidation (GO:0006069) | 4.09991566 |
| 72 | metanephric nephron tubule development (GO:0072234) | 4.07308020 |
| 73 | metanephric tubule development (GO:0072170) | 4.07308020 |
| 74 | cellular glucuronidation (GO:0052695) | 4.05288245 |
| 75 | serine family amino acid biosynthetic process (GO:0009070) | 4.03598133 |
| 76 | cholesterol efflux (GO:0033344) | 4.02108139 |
| 77 | drug catabolic process (GO:0042737) | 3.98098696 |
| 78 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.96509612 |
| 79 | low-density lipoprotein particle remodeling (GO:0034374) | 3.95290373 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 3.93282171 |
| 81 | oxidative demethylation (GO:0070989) | 3.93159717 |
| 82 | aldehyde catabolic process (GO:0046185) | 3.93005864 |
| 83 | short-chain fatty acid metabolic process (GO:0046459) | 3.90917225 |
| 84 | fibrinolysis (GO:0042730) | 3.89968496 |
| 85 | metanephric nephron epithelium development (GO:0072243) | 3.89709781 |
| 86 | urate metabolic process (GO:0046415) | 3.89631846 |
| 87 | arginine metabolic process (GO:0006525) | 3.88525360 |
| 88 | protein-chromophore linkage (GO:0018298) | 3.85604675 |
| 89 | ketone body metabolic process (GO:1902224) | 3.82572274 |
| 90 | organic acid catabolic process (GO:0016054) | 3.77967306 |
| 91 | carboxylic acid catabolic process (GO:0046395) | 3.77967306 |
| 92 | sodium-independent organic anion transport (GO:0043252) | 3.77530904 |
| 93 | acetyl-CoA metabolic process (GO:0006084) | 3.76282536 |
| 94 | epoxygenase P450 pathway (GO:0019373) | 3.73747995 |
| 95 | metanephric epithelium development (GO:0072207) | 3.72227861 |
| 96 | positive regulation of lipid catabolic process (GO:0050996) | 3.71589322 |
| 97 | phospholipid homeostasis (GO:0055091) | 3.71039826 |
| 98 | blood coagulation, intrinsic pathway (GO:0007597) | 3.70482428 |
| 99 | drug transmembrane transport (GO:0006855) | 3.70355126 |
| 100 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.68373238 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.68373238 |
| 102 | S-adenosylmethionine metabolic process (GO:0046500) | 3.67220612 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.66013984 |
| 104 | cytolysis (GO:0019835) | 3.65612855 |
| 105 | cofactor catabolic process (GO:0051187) | 3.63858901 |
| 106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.63782516 |
| 107 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.63287977 |
| 108 | glucuronate metabolic process (GO:0019585) | 3.62318608 |
| 109 | uronic acid metabolic process (GO:0006063) | 3.62318608 |
| 110 | sterol homeostasis (GO:0055092) | 3.60556685 |
| 111 | 2-oxoglutarate metabolic process (GO:0006103) | 3.60121129 |
| 112 | complement activation (GO:0006956) | 3.59087644 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 3.57872712 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.57674368 |
| 115 | protein activation cascade (GO:0072376) | 3.57482257 |
| 116 | negative regulation of lipase activity (GO:0060192) | 3.56639609 |
| 117 | aspartate family amino acid catabolic process (GO:0009068) | 3.55620096 |
| 118 | neurotransmitter catabolic process (GO:0042135) | 3.55608942 |
| 119 | regulation of plasminogen activation (GO:0010755) | 3.53238244 |
| 120 | opsonization (GO:0008228) | 3.48144248 |
| 121 | cell volume homeostasis (GO:0006884) | 3.43042301 |
| 122 | organic cation transport (GO:0015695) | 3.42985998 |
| 123 | regulation of apoptotic cell clearance (GO:2000425) | 3.37325462 |
| 124 | phosphate ion transport (GO:0006817) | 3.36330149 |
| 125 | peripheral nervous system axon ensheathment (GO:0032292) | 3.34236248 |
| 126 | myelination in peripheral nervous system (GO:0022011) | 3.34236248 |
| 127 | ethanol metabolic process (GO:0006067) | 3.34235728 |
| 128 | negative regulation of metanephros development (GO:0072217) | 3.32988407 |
| 129 | quaternary ammonium group transport (GO:0015697) | 3.32282271 |
| 130 | negative regulation of protein activation cascade (GO:2000258) | 3.30291860 |
| 131 | regulation of humoral immune response (GO:0002920) | 3.06460214 |
| 132 | drug transport (GO:0015893) | 3.01442448 |
| 133 | positive regulation of p38MAPK cascade (GO:1900745) | 2.96956180 |
| 134 | fat-soluble vitamin metabolic process (GO:0006775) | 2.96892534 |
| 135 | phenylpropanoid metabolic process (GO:0009698) | 2.95207292 |
| 136 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.94808895 |
| 137 | cellular hyperosmotic response (GO:0071474) | 2.93365357 |
| 138 | negative regulation of complement activation (GO:0045916) | 2.92792951 |
| 139 | carnitine metabolic process (GO:0009437) | 2.92511407 |
| 140 | phosphate ion transmembrane transport (GO:0035435) | 2.91634557 |
| 141 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.89764002 |
| 142 | detection of light stimulus involved in visual perception (GO:0050908) | 2.89764002 |
| 143 | xenobiotic catabolic process (GO:0042178) | 2.89231127 |
| 144 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.86014232 |
| 145 | retinal metabolic process (GO:0042574) | 2.83451519 |
| 146 | regulation of p38MAPK cascade (GO:1900744) | 2.83266219 |
| 147 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.81069788 |
| 148 | nephron tubule development (GO:0072080) | 2.74927537 |
| 149 | flavonoid metabolic process (GO:0009812) | 2.74481610 |
| 150 | xenobiotic metabolic process (GO:0006805) | 2.73260206 |
| 151 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.71347413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.31335481 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13128961 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.77684622 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.42532762 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.16117392 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.15148213 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.97868201 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.93413339 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93380415 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.97082356 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.33659236 |
| 12 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.30440987 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16106460 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.11476386 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00844147 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8121855 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.97344453 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.69062694 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.63224479 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.61907155 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61145197 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60940693 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.60474500 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.50298021 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.50298021 |
| 26 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.44251893 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43493099 |
| 28 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42142352 |
| 29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39696666 |
| 30 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.38781580 |
| 31 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.38631186 |
| 32 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.38088387 |
| 33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.36120245 |
| 34 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.35936636 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35466516 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.35258665 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25628385 |
| 38 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.24686462 |
| 39 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.22727585 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22186951 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.20335600 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16950010 |
| 43 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15746999 |
| 44 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11827618 |
| 45 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11583842 |
| 46 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.10940111 |
| 47 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.10202995 |
| 48 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.07410721 |
| 49 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06865558 |
| 50 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04305724 |
| 51 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03987061 |
| 52 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03252231 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.01639532 |
| 54 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00976941 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99081037 |
| 56 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.98750450 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.98619248 |
| 58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95749538 |
| 59 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94230178 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94138296 |
| 61 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.93045724 |
| 62 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.92297882 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91786957 |
| 64 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91005205 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90522363 |
| 66 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89845722 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89532689 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89484258 |
| 69 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89406412 |
| 70 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88379891 |
| 71 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.86660803 |
| 72 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86565473 |
| 73 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85482677 |
| 74 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.85229501 |
| 75 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85172071 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.83425022 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.83289940 |
| 78 | AR_19668381_ChIP-Seq_PC3_Human | 0.83145067 |
| 79 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.83111097 |
| 80 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.82641844 |
| 81 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.82007839 |
| 82 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81953103 |
| 83 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.81743817 |
| 84 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81538638 |
| 85 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.81045894 |
| 86 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80984185 |
| 87 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.80934930 |
| 88 | TBL1_22424771_ChIP-Seq_293T_Human | 0.80614382 |
| 89 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.80470389 |
| 90 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.80364913 |
| 91 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.80208067 |
| 92 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80021678 |
| 93 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79668536 |
| 94 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.79615258 |
| 95 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79260957 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79188577 |
| 97 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78622866 |
| 98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.78039602 |
| 99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.77768046 |
| 100 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.77300657 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77270945 |
| 102 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.76879926 |
| 103 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.76138831 |
| 104 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.75573442 |
| 105 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75411730 |
| 106 | NFYA_21822215_ChIP-Seq_K562_Human | 0.75237000 |
| 107 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.74469886 |
| 108 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.74467609 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.74261835 |
| 110 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.73840823 |
| 111 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.73627728 |
| 112 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73516482 |
| 113 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.73493914 |
| 114 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72819861 |
| 115 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71715488 |
| 116 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71656501 |
| 117 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67546351 |
| 118 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65658502 |
| 119 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.65432379 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65375454 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64931947 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64194643 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64194643 |
| 124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.60116503 |
| 125 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60107962 |
| 126 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59698247 |
| 127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59270206 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.58789310 |
| 129 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56912278 |
| 130 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56129410 |
| 131 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55959845 |
| 132 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.55188844 |
| 133 | GATA2_19941826_ChIP-Seq_K562_Human | 0.54661325 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.54080652 |
| 135 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54047670 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52065875 |
| 137 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51208107 |
| 138 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.51104738 |
| 139 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.50832676 |
| 140 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49512615 |
| 141 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48708840 |
| 142 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.47481700 |
| 143 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46788537 |
| 144 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46453779 |
| 145 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.46299862 |
| 146 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.45097856 |
| 147 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44711163 |
| 148 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43829982 |
| 149 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.43587959 |
| 150 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.41898183 |
| 151 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.41738411 |
| 152 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.41061421 |
| 153 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41012748 |
| 154 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.40182145 |
| 155 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.38360435 |
| 156 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37468018 |
| 157 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36133899 |
| 158 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36007505 |
| 159 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.35668988 |
| 160 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.35361177 |
| 161 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.35105587 |
| 162 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.34996476 |
| 163 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34833004 |
| 164 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.34011425 |
| 165 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.33588527 |
| 166 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.33362568 |
| 167 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.32907439 |
| 168 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.32734712 |
| 169 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.32619324 |
| 170 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.32379212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.18034161 |
| 2 | MP0005360_urolithiasis | 7.67872482 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.16807782 |
| 4 | MP0005365_abnormal_bile_salt | 6.03089975 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.99397401 |
| 6 | MP0003879_abnormal_hair_cell | 4.64823346 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.14332305 |
| 8 | MP0003252_abnormal_bile_duct | 3.76064781 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.56632941 |
| 10 | MP0003195_calcinosis | 3.36283261 |
| 11 | MP0009840_abnormal_foam_cell | 3.20861727 |
| 12 | MP0005377_hearing/vestibular/ear_phenot | 3.10479084 |
| 13 | MP0003878_abnormal_ear_physiology | 3.10479084 |
| 14 | MP0005332_abnormal_amino_acid | 2.98787391 |
| 15 | MP0005083_abnormal_biliary_tract | 2.80569633 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.48923762 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.47670331 |
| 18 | MP0001986_abnormal_taste_sensitivity | 2.46245222 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.37613798 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.33326030 |
| 21 | MP0000609_abnormal_liver_physiology | 2.13039976 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.10539093 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.09343422 |
| 24 | MP0002735_abnormal_chemical_nociception | 2.02923002 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 2.00287078 |
| 26 | MP0002653_abnormal_ependyma_morphology | 1.85451556 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.83307500 |
| 28 | MP0003868_abnormal_feces_composition | 1.75088433 |
| 29 | MP0001764_abnormal_homeostasis | 1.72871468 |
| 30 | MP0005551_abnormal_eye_electrophysiolog | 1.71949022 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63606531 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.56068460 |
| 33 | MP0001324_abnormal_eye_pigmentation | 1.50601776 |
| 34 | MP0009697_abnormal_copulation | 1.46533267 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.46492665 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.43519841 |
| 37 | MP0003011_delayed_dark_adaptation | 1.37540672 |
| 38 | MP0003186_abnormal_redox_activity | 1.36383115 |
| 39 | MP0005451_abnormal_body_composition | 1.32519037 |
| 40 | MP0005253_abnormal_eye_physiology | 1.29895141 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.26700684 |
| 42 | MP0004859_abnormal_synaptic_plasticity | 1.20205629 |
| 43 | MP0000598_abnormal_liver_morphology | 1.18264618 |
| 44 | MP0002272_abnormal_nervous_system | 1.17573545 |
| 45 | MP0001879_abnormal_lymphatic_vessel | 1.16251479 |
| 46 | MP0000920_abnormal_myelination | 1.10919049 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 1.09745429 |
| 48 | MP0000604_amyloidosis | 1.07931591 |
| 49 | MP0005647_abnormal_sex_gland | 1.07297143 |
| 50 | MP0009764_decreased_sensitivity_to | 1.06980500 |
| 51 | MP0005670_abnormal_white_adipose | 1.06525658 |
| 52 | MP0002229_neurodegeneration | 1.05836853 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.05392985 |
| 54 | MP0001486_abnormal_startle_reflex | 1.05073903 |
| 55 | MP0009763_increased_sensitivity_to | 1.03839712 |
| 56 | MP0003959_abnormal_lean_body | 0.95809533 |
| 57 | MP0008469_abnormal_protein_level | 0.93594033 |
| 58 | MP0002254_reproductive_system_inflammat | 0.92270655 |
| 59 | MP0005187_abnormal_penis_morphology | 0.92173778 |
| 60 | MP0010386_abnormal_urinary_bladder | 0.91534246 |
| 61 | MP0009642_abnormal_blood_homeostasis | 0.89835181 |
| 62 | MP0002090_abnormal_vision | 0.89643159 |
| 63 | MP0009745_abnormal_behavioral_response | 0.86737970 |
| 64 | MP0002249_abnormal_larynx_morphology | 0.84695448 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 0.84578709 |
| 66 | MP0002876_abnormal_thyroid_physiology | 0.84410048 |
| 67 | MP0003633_abnormal_nervous_system | 0.83972738 |
| 68 | MP0003631_nervous_system_phenotype | 0.82734983 |
| 69 | MP0003690_abnormal_glial_cell | 0.81225828 |
| 70 | MP0004130_abnormal_muscle_cell | 0.81169911 |
| 71 | MP0003634_abnormal_glial_cell | 0.80956496 |
| 72 | MP0005376_homeostasis/metabolism_phenot | 0.80557555 |
| 73 | MP0009765_abnormal_xenobiotic_induced | 0.78754528 |
| 74 | MP0010368_abnormal_lymphatic_system | 0.78454828 |
| 75 | MP0005408_hypopigmentation | 0.78412801 |
| 76 | MP0002557_abnormal_social/conspecific_i | 0.77462399 |
| 77 | MP0001756_abnormal_urination | 0.76763809 |
| 78 | MP0002078_abnormal_glucose_homeostasis | 0.75270198 |
| 79 | MP0005535_abnormal_body_temperature | 0.74962049 |
| 80 | MP0001440_abnormal_grooming_behavior | 0.74706126 |
| 81 | MP0002971_abnormal_brown_adipose | 0.74373790 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 0.73939415 |
| 83 | MP0001661_extended_life_span | 0.72509405 |
| 84 | MP0003632_abnormal_nervous_system | 0.72119589 |
| 85 | MP0005464_abnormal_platelet_physiology | 0.71966338 |
| 86 | MP0008569_lethality_at_weaning | 0.70181047 |
| 87 | MP0005334_abnormal_fat_pad | 0.68800872 |
| 88 | MP0002063_abnormal_learning/memory/cond | 0.68437015 |
| 89 | MP0002638_abnormal_pupillary_reflex | 0.67687614 |
| 90 | MP0005391_vision/eye_phenotype | 0.66749898 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.66369359 |
| 92 | MP0001963_abnormal_hearing_physiology | 0.65435333 |
| 93 | MP0002572_abnormal_emotion/affect_behav | 0.65025408 |
| 94 | MP0002736_abnormal_nociception_after | 0.64622706 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 0.64569207 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.62849174 |
| 97 | MP0001348_abnormal_lacrimal_gland | 0.62818767 |
| 98 | MP0005623_abnormal_meninges_morphology | 0.62751495 |
| 99 | MP0005195_abnormal_posterior_eye | 0.62665816 |
| 100 | MP0000747_muscle_weakness | 0.62615018 |
| 101 | MP0003329_amyloid_beta_deposits | 0.62505090 |
| 102 | MP0004233_abnormal_muscle_weight | 0.60546136 |
| 103 | MP0005266_abnormal_metabolism | 0.60441536 |
| 104 | MP0002067_abnormal_sensory_capabilities | 0.59773331 |
| 105 | MP0002064_seizures | 0.59710816 |
| 106 | MP0003724_increased_susceptibility_to | 0.59554303 |
| 107 | MP0000639_abnormal_adrenal_gland | 0.59510614 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.59131925 |
| 109 | MP0005257_abnormal_intraocular_pressure | 0.57557240 |
| 110 | MP0002282_abnormal_trachea_morphology | 0.57352362 |
| 111 | MP0000026_abnormal_inner_ear | 0.57004162 |
| 112 | MP0001968_abnormal_touch/_nociception | 0.56936140 |
| 113 | MP0001970_abnormal_pain_threshold | 0.56405862 |
| 114 | MP0002132_abnormal_respiratory_system | 0.55306508 |
| 115 | MP0006035_abnormal_mitochondrial_morpho | 0.54844413 |
| 116 | MP0004742_abnormal_vestibular_system | 0.53510083 |
| 117 | MP0009046_muscle_twitch | 0.53494631 |
| 118 | MP0009053_abnormal_anal_canal | 0.51199412 |
| 119 | MP0005395_other_phenotype | 0.50780278 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.50427134 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.49529884 |
| 122 | MP0005448_abnormal_energy_balance | 0.48180339 |
| 123 | MP0008873_increased_physiological_sensi | 0.46819920 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.46134119 |
| 125 | MP0003436_decreased_susceptibility_to | 0.45454957 |
| 126 | MP0008874_decreased_physiological_sensi | 0.44924878 |
| 127 | MP0002928_abnormal_bile_duct | 0.44870167 |
| 128 | MP0002168_other_aberrant_phenotype | 0.43803036 |
| 129 | MP0003075_altered_response_to | 0.42396534 |
| 130 | MP0001853_heart_inflammation | 0.41041717 |
| 131 | MP0003953_abnormal_hormone_level | 0.40815502 |
| 132 | MP0005167_abnormal_blood-brain_barrier | 0.40241639 |
| 133 | MP0004043_abnormal_pH_regulation | 0.39608878 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.38761696 |
| 135 | MP0001765_abnormal_ion_homeostasis | 0.37538321 |
| 136 | MP0004381_abnormal_hair_follicle | 0.36603694 |
| 137 | MP0001845_abnormal_inflammatory_respons | 0.36563738 |
| 138 | MP0005166_decreased_susceptibility_to | 0.36315151 |
| 139 | MP0000230_abnormal_systemic_arterial | 0.36136843 |
| 140 | MP0009115_abnormal_fat_cell | 0.36030559 |
| 141 | MP0006082_CNS_inflammation | 0.35610986 |
| 142 | MP0008872_abnormal_physiological_respon | 0.35237913 |
| 143 | MP0002837_dystrophic_cardiac_calcinosis | 0.34697300 |
| 144 | MP0000249_abnormal_blood_vessel | 0.34469495 |
| 145 | MP0003718_maternal_effect | 0.33977250 |
| 146 | MP0002135_abnormal_kidney_morphology | 0.33919634 |
| 147 | MP0004264_abnormal_extraembryonic_tissu | 0.33373789 |
| 148 | MP0002970_abnormal_white_adipose | 0.33165790 |
| 149 | MP0002796_impaired_skin_barrier | 0.32632352 |
| 150 | MP0004883_abnormal_blood_vessel | 0.32574726 |
| 151 | MP0002822_catalepsy | 0.32403434 |
| 152 | MP0009672_abnormal_birth_weight | 0.31953993 |
| 153 | MP0005164_abnormal_response_to | 0.30832629 |
| 154 | MP0000579_abnormal_nail_morphology | 0.30616843 |
| 155 | MP0001243_abnormal_dermal_layer | 0.28331311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.14134825 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.10366463 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.05638252 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.37124247 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.21637076 |
| 6 | Xanthomatosis (HP:0000991) | 6.19579748 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.96667399 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.49022845 |
| 9 | Nuclear cataract (HP:0100018) | 5.32250222 |
| 10 | Complement deficiency (HP:0004431) | 5.22430124 |
| 11 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.93101876 |
| 12 | Increased circulating renin level (HP:0000848) | 4.89241496 |
| 13 | Joint hemorrhage (HP:0005261) | 4.72856739 |
| 14 | Hyperammonemia (HP:0001987) | 4.65848980 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.57555611 |
| 16 | Hyperglycinemia (HP:0002154) | 4.50936308 |
| 17 | Facial shape deformation (HP:0011334) | 4.47244601 |
| 18 | Potter facies (HP:0002009) | 4.47244601 |
| 19 | Ketosis (HP:0001946) | 4.35566834 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.33499160 |
| 21 | Hyperglycinuria (HP:0003108) | 4.31753896 |
| 22 | Epidermoid cyst (HP:0200040) | 4.27522507 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.26169597 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.22371195 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22036495 |
| 26 | Metabolic alkalosis (HP:0200114) | 4.20383397 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.18340829 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 4.17842453 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.17842453 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 4.12157008 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 4.10343046 |
| 32 | Hypomagnesemia (HP:0002917) | 4.09192741 |
| 33 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 4.03335544 |
| 34 | Fat malabsorption (HP:0002630) | 3.97401221 |
| 35 | Hypokalemic alkalosis (HP:0001949) | 3.93265704 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.79658807 |
| 37 | Abnormality of complement system (HP:0005339) | 3.77508892 |
| 38 | Polyuria (HP:0000103) | 3.72181376 |
| 39 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.64342712 |
| 40 | Abnormal urine output (HP:0012590) | 3.59782910 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.54826251 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.50575500 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.49842802 |
| 44 | Conjugated hyperbilirubinemia (HP:0002908) | 3.44759020 |
| 45 | Hyperactive renin-angiotensin system (HP:0000841) | 3.36331885 |
| 46 | Abnormality of magnesium homeostasis (HP:0004921) | 3.36200788 |
| 47 | Polydipsia (HP:0001959) | 3.34038638 |
| 48 | Abnormal drinking behavior (HP:0030082) | 3.34038638 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33211736 |
| 50 | Hyperbilirubinemia (HP:0002904) | 3.30274907 |
| 51 | Delayed CNS myelination (HP:0002188) | 3.26785706 |
| 52 | Ketoacidosis (HP:0001993) | 3.19492756 |
| 53 | Abnormality of renal excretion (HP:0011036) | 3.17466699 |
| 54 | Abnormality of nucleobase metabolism (HP:0010932) | 3.16521553 |
| 55 | Tubular atrophy (HP:0000092) | 3.14092984 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 3.10219963 |
| 57 | Myocardial infarction (HP:0001658) | 3.10066587 |
| 58 | Abnormality of chloride homeostasis (HP:0011422) | 3.08593819 |
| 59 | Hepatocellular carcinoma (HP:0001402) | 3.03356085 |
| 60 | Steatorrhea (HP:0002570) | 3.00208024 |
| 61 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.99138158 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.92610973 |
| 63 | Chronic hepatic failure (HP:0100626) | 2.91348319 |
| 64 | Focal segmental glomerulosclerosis (HP:0000097) | 2.90792189 |
| 65 | Gout (HP:0001997) | 2.89722702 |
| 66 | Abnormal ciliary motility (HP:0012262) | 2.88995876 |
| 67 | Decreased central vision (HP:0007663) | 2.88973341 |
| 68 | Macular degeneration (HP:0000608) | 2.88566782 |
| 69 | Abnormality of macular pigmentation (HP:0008002) | 2.86042747 |
| 70 | Metabolic acidosis (HP:0001942) | 2.85774381 |
| 71 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.85235656 |
| 72 | Vascular calcification (HP:0004934) | 2.82178352 |
| 73 | Spontaneous abortion (HP:0005268) | 2.80878660 |
| 74 | Choroideremia (HP:0001139) | 2.77416134 |
| 75 | Hyperaldosteronism (HP:0000859) | 2.75621838 |
| 76 | Congenital stationary night blindness (HP:0007642) | 2.73728240 |
| 77 | Action tremor (HP:0002345) | 2.70942419 |
| 78 | Myokymia (HP:0002411) | 2.70760709 |
| 79 | Systemic lupus erythematosus (HP:0002725) | 2.70677546 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 2.69215019 |
| 81 | Scotoma (HP:0000575) | 2.68937273 |
| 82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.68807580 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 2.68807580 |
| 84 | Ulnar claw (HP:0001178) | 2.66820924 |
| 85 | Skin nodule (HP:0200036) | 2.64017538 |
| 86 | Lethargy (HP:0001254) | 2.63640056 |
| 87 | Osteomalacia (HP:0002749) | 2.61192052 |
| 88 | Attenuation of retinal blood vessels (HP:0007843) | 2.59942936 |
| 89 | Renal salt wasting (HP:0000127) | 2.58175666 |
| 90 | Rhinitis (HP:0012384) | 2.56616462 |
| 91 | Zonular cataract (HP:0010920) | 2.54724806 |
| 92 | Cardiovascular calcification (HP:0011915) | 2.50078116 |
| 93 | Acanthocytosis (HP:0001927) | 2.46224715 |
| 94 | Glomerulonephritis (HP:0000099) | 2.44816332 |
| 95 | Spastic diplegia (HP:0001264) | 2.42796510 |
| 96 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.41807733 |
| 97 | Occipital encephalocele (HP:0002085) | 2.40813403 |
| 98 | Neonatal onset (HP:0003623) | 2.37760282 |
| 99 | Mitral stenosis (HP:0001718) | 2.37067514 |
| 100 | Metaphyseal dysplasia (HP:0100255) | 2.36477851 |
| 101 | Glomerulosclerosis (HP:0000096) | 2.35766229 |
| 102 | Irritability (HP:0000737) | 2.33625980 |
| 103 | Hypoglycemic seizures (HP:0002173) | 2.33381136 |
| 104 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33210490 |
| 105 | Polar cataract (HP:0010696) | 2.32030398 |
| 106 | Abnormal gallbladder morphology (HP:0012437) | 2.30053603 |
| 107 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.27899843 |
| 108 | Cerebral edema (HP:0002181) | 2.27678328 |
| 109 | Malnutrition (HP:0004395) | 2.26094046 |
| 110 | Generalized aminoaciduria (HP:0002909) | 2.26086841 |
| 111 | Sensorimotor neuropathy (HP:0007141) | 2.25677658 |
| 112 | Cholelithiasis (HP:0001081) | 2.25477744 |
| 113 | Enlarged kidneys (HP:0000105) | 2.21810985 |
| 114 | Pancreatitis (HP:0001733) | 2.19441276 |
| 115 | Abnormal biliary tract physiology (HP:0012439) | 2.18283588 |
| 116 | Bile duct proliferation (HP:0001408) | 2.18283588 |
| 117 | Amyloidosis (HP:0011034) | 2.18261856 |
| 118 | Alkalosis (HP:0001948) | 2.17205140 |
| 119 | Gingival bleeding (HP:0000225) | 2.16970697 |
| 120 | Menorrhagia (HP:0000132) | 2.16701708 |
| 121 | Vomiting (HP:0002013) | 2.15702508 |
| 122 | Esophageal varix (HP:0002040) | 2.15070924 |
| 123 | Abnormal gallbladder physiology (HP:0012438) | 2.15031123 |
| 124 | Cholecystitis (HP:0001082) | 2.15031123 |
| 125 | Late onset (HP:0003584) | 2.13553860 |
| 126 | Rickets (HP:0002748) | 2.13457420 |
| 127 | Hypophosphatemic rickets (HP:0004912) | 2.10719762 |
| 128 | Hyperphosphaturia (HP:0003109) | 2.10562530 |
| 129 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.09052372 |
| 130 | Absent/shortened dynein arms (HP:0200106) | 2.09052372 |
| 131 | Abnormality of the fingertips (HP:0001211) | 2.08304233 |
| 132 | Nephritis (HP:0000123) | 2.07571366 |
| 133 | Hemorrhage of the eye (HP:0011885) | 2.06889675 |
| 134 | Abnormality of iron homeostasis (HP:0011031) | 2.05973772 |
| 135 | Thrombophlebitis (HP:0004418) | 2.05560017 |
| 136 | Proximal tubulopathy (HP:0000114) | 2.04444548 |
| 137 | Brushfield spots (HP:0001088) | 2.04417035 |
| 138 | Abnormality of renin-angiotensin system (HP:0000847) | 2.03862032 |
| 139 | Increased purine levels (HP:0004368) | 2.03807193 |
| 140 | Hyperuricemia (HP:0002149) | 2.03807193 |
| 141 | Chorioretinal atrophy (HP:0000533) | 2.02047580 |
| 142 | Nasal polyposis (HP:0100582) | 2.01175907 |
| 143 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.01164682 |
| 144 | Termporal pattern (HP:0011008) | 1.99557509 |
| 145 | Insidious onset (HP:0003587) | 1.99557509 |
| 146 | Abnormality of proline metabolism (HP:0010907) | 1.98369638 |
| 147 | Hydroxyprolinuria (HP:0003080) | 1.98369638 |
| 148 | Recurrent sinusitis (HP:0011108) | 1.98027243 |
| 149 | Opisthotonus (HP:0002179) | 1.97457714 |
| 150 | Hypokalemia (HP:0002900) | 1.97200239 |
| 151 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.96743666 |
| 152 | Tubulointerstitial fibrosis (HP:0005576) | 1.94123663 |
| 153 | Abnormality of the nasal mucosa (HP:0000433) | 1.93998874 |
| 154 | Abnormal cartilage morphology (HP:0002763) | 1.93584045 |
| 155 | Poikilocytosis (HP:0004447) | 1.92925104 |
| 156 | Abnormality of the gallbladder (HP:0005264) | 1.89885860 |
| 157 | Abnormality of urine glucose concentration (HP:0011016) | 1.89811009 |
| 158 | Glycosuria (HP:0003076) | 1.89811009 |
| 159 | Portal hypertension (HP:0001409) | 1.85648054 |
| 160 | Stage 5 chronic kidney disease (HP:0003774) | 1.85449899 |
| 161 | Elevated hepatic transaminases (HP:0002910) | 1.84355017 |
| 162 | Genetic anticipation (HP:0003743) | 1.84237842 |
| 163 | Peripheral hypomyelination (HP:0007182) | 1.84234766 |
| 164 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84161008 |
| 165 | Confusion (HP:0001289) | 1.82483826 |
| 166 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.81781883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.26865074 |
| 2 | FGFR4 | 4.51728486 |
| 3 | SIK1 | 4.50165810 |
| 4 | ERN1 | 3.95417035 |
| 5 | NTRK3 | 3.36090560 |
| 6 | TAOK3 | 2.97890296 |
| 7 | CDK12 | 2.88502108 |
| 8 | STK38 | 2.77160428 |
| 9 | INSRR | 2.60810167 |
| 10 | ERBB4 | 2.55768348 |
| 11 | EPHA4 | 2.30006024 |
| 12 | BRD4 | 2.18948956 |
| 13 | PDK2 | 2.12575738 |
| 14 | PKN2 | 2.08237938 |
| 15 | TRIB3 | 2.07609907 |
| 16 | MST1R | 2.05470794 |
| 17 | MAP2K4 | 1.99770726 |
| 18 | MAPK11 | 1.87688249 |
| 19 | TYK2 | 1.86452805 |
| 20 | FLT3 | 1.72553077 |
| 21 | PIK3CG | 1.61125852 |
| 22 | CAMK1G | 1.60127439 |
| 23 | CAMK1D | 1.58246612 |
| 24 | PTK6 | 1.47274327 |
| 25 | PRKAA2 | 1.46407736 |
| 26 | KDR | 1.40270062 |
| 27 | ABL2 | 1.39617454 |
| 28 | DAPK2 | 1.39559382 |
| 29 | PTK2B | 1.36264686 |
| 30 | GRK6 | 1.32643790 |
| 31 | NTRK2 | 1.29972135 |
| 32 | JAK2 | 1.29022868 |
| 33 | MAP3K7 | 1.28033692 |
| 34 | PRKD3 | 1.27510478 |
| 35 | FER | 1.26720065 |
| 36 | NEK9 | 1.26232647 |
| 37 | STK39 | 1.25673137 |
| 38 | FGFR2 | 1.20547988 |
| 39 | MAP2K3 | 1.07926589 |
| 40 | TBK1 | 1.07432979 |
| 41 | MARK1 | 1.05943566 |
| 42 | MAPK4 | 1.03026753 |
| 43 | NEK6 | 1.02191113 |
| 44 | PINK1 | 1.01857240 |
| 45 | JAK1 | 1.00758515 |
| 46 | DYRK1A | 1.00147630 |
| 47 | FRK | 0.98412925 |
| 48 | MAP3K14 | 0.97840799 |
| 49 | LATS1 | 0.96557533 |
| 50 | EPHB1 | 0.91779998 |
| 51 | ERBB2 | 0.91195015 |
| 52 | MAP3K10 | 0.89304789 |
| 53 | PRKCZ | 0.87478626 |
| 54 | MAPK12 | 0.87360494 |
| 55 | SGK1 | 0.85849581 |
| 56 | CSK | 0.84077364 |
| 57 | PRKACG | 0.82866596 |
| 58 | SGK3 | 0.82599489 |
| 59 | TIE1 | 0.82435621 |
| 60 | WNK3 | 0.79888524 |
| 61 | CASK | 0.78170995 |
| 62 | FGR | 0.77332583 |
| 63 | CAMKK1 | 0.74586784 |
| 64 | PHKG2 | 0.74146928 |
| 65 | PHKG1 | 0.74146928 |
| 66 | PRKAA1 | 0.73906996 |
| 67 | DYRK1B | 0.73797302 |
| 68 | MAP3K13 | 0.73089018 |
| 69 | TGFBR2 | 0.72721716 |
| 70 | GSK3A | 0.72602600 |
| 71 | CDK6 | 0.72442477 |
| 72 | MET | 0.72212487 |
| 73 | MAP3K3 | 0.70808164 |
| 74 | CDK5 | 0.69018948 |
| 75 | CAMK2G | 0.68833020 |
| 76 | MAPKAPK3 | 0.68042823 |
| 77 | MAP4K1 | 0.66690757 |
| 78 | MAP2K6 | 0.66432968 |
| 79 | ARAF | 0.65282357 |
| 80 | LATS2 | 0.63784494 |
| 81 | MAPK15 | 0.63422430 |
| 82 | ITK | 0.63149588 |
| 83 | IKBKE | 0.63090897 |
| 84 | STK38L | 0.62720656 |
| 85 | CSF1R | 0.62624416 |
| 86 | NTRK1 | 0.62614921 |
| 87 | FGFR3 | 0.62418725 |
| 88 | MAP3K11 | 0.62306115 |
| 89 | SGK2 | 0.61342324 |
| 90 | EPHA3 | 0.58233086 |
| 91 | PAK6 | 0.57915434 |
| 92 | CDK9 | 0.57348556 |
| 93 | IRAK3 | 0.57263409 |
| 94 | PRKCQ | 0.56870439 |
| 95 | PTK2 | 0.55185942 |
| 96 | SGK223 | 0.54636742 |
| 97 | SGK494 | 0.54636742 |
| 98 | MAPK7 | 0.54065683 |
| 99 | PRKACA | 0.53644735 |
| 100 | PDPK1 | 0.52346956 |
| 101 | RIPK1 | 0.52232366 |
| 102 | CAMK4 | 0.49769481 |
| 103 | IGF1R | 0.47550957 |
| 104 | PLK2 | 0.47343897 |
| 105 | CSNK1G1 | 0.46956362 |
| 106 | CDK4 | 0.46000351 |
| 107 | MAPK10 | 0.45617775 |
| 108 | KSR2 | 0.42735506 |
| 109 | FES | 0.41474826 |
| 110 | MAP3K9 | 0.41473940 |
| 111 | RPS6KA2 | 0.40763414 |
| 112 | PRKCG | 0.40279480 |
| 113 | RPS6KA3 | 0.40278700 |
| 114 | WNK4 | 0.40088242 |
| 115 | MARK2 | 0.38457981 |
| 116 | OXSR1 | 0.38441357 |
| 117 | PDK1 | 0.38321425 |
| 118 | TYRO3 | 0.37094126 |
| 119 | PKN1 | 0.36768059 |
| 120 | AKT2 | 0.35253187 |
| 121 | GRK5 | 0.35207650 |
| 122 | GRK1 | 0.33574614 |
| 123 | MAP2K1 | 0.33431264 |
| 124 | MTOR | 0.33219017 |
| 125 | SIK2 | 0.33172500 |
| 126 | PIK3CA | 0.32598178 |
| 127 | RET | 0.32262549 |
| 128 | JAK3 | 0.32085519 |
| 129 | ADRBK1 | 0.31822748 |
| 130 | MAPK13 | 0.31821246 |
| 131 | MAP3K6 | 0.31689417 |
| 132 | DDR2 | 0.31213867 |
| 133 | MELK | 0.31093824 |
| 134 | TAOK2 | 0.31053754 |
| 135 | ROCK1 | 0.31005892 |
| 136 | EGFR | 0.30863326 |
| 137 | EPHB2 | 0.30642946 |
| 138 | MAP3K5 | 0.30020457 |
| 139 | MAP2K2 | 0.29962003 |
| 140 | PRKCA | 0.29879226 |
| 141 | MUSK | 0.29629104 |
| 142 | UHMK1 | 0.29000536 |
| 143 | BLK | 0.28625421 |
| 144 | CAMK2A | 0.28007351 |
| 145 | PRKD1 | 0.27834547 |
| 146 | LRRK2 | 0.26981554 |
| 147 | SRC | 0.26556970 |
| 148 | BTK | 0.26010146 |
| 149 | PDK4 | 0.25662588 |
| 150 | PDK3 | 0.25662588 |
| 151 | PRKCH | 0.25653403 |
| 152 | MAPK3 | 0.25357263 |
| 153 | BMX | 0.24550953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39863716 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.84447110 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32849222 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.23003592 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.02714995 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72464217 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.71092584 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.70103064 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62963885 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52666159 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50658959 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46239908 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26256965 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18684893 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.11832559 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07923752 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03291895 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92938683 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90671793 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90222760 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87128798 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85186950 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85106116 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79552031 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74412494 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.70616314 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68959462 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67994521 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63504754 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62732630 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62244515 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.61296309 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59489955 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.53183558 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49119658 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41884246 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40847582 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36554568 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30520864 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30243059 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29207063 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26914254 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18676703 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.18123733 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17515904 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16471086 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15723457 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09732109 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09670319 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09000568 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07908530 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 1.06116374 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96864584 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96350581 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96342320 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94935401 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93133396 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91382104 |
| 59 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90905320 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.86398406 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73686695 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72751779 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70044426 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69454967 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62150257 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56183969 |
| 67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.56096461 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55736278 |
| 69 | Nicotine addiction_Homo sapiens_hsa05033 | 0.54478541 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46857019 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44914223 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40729045 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38036976 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36011204 |
| 75 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.32235037 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.30294474 |
| 77 | * GABAergic synapse_Homo sapiens_hsa04727 | 0.27253539 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26448424 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.25218580 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24576371 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.24311483 |
| 82 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.24137877 |
| 83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.23938996 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23849897 |
| 85 | Cocaine addiction_Homo sapiens_hsa05030 | 0.23040610 |
| 86 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.21095078 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20413210 |
| 88 | Insulin secretion_Homo sapiens_hsa04911 | 0.19682090 |
| 89 | Morphine addiction_Homo sapiens_hsa05032 | 0.19574121 |
| 90 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.18977538 |
| 91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.18796375 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.15639587 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14351778 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14026412 |
| 95 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.14020338 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.13220402 |
| 97 | Circadian entrainment_Homo sapiens_hsa04713 | 0.12271712 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.12174587 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.11650415 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.10792232 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07538826 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03920895 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | -0.2383659 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2376448 |
| 105 | Lysosome_Homo sapiens_hsa04142 | -0.2298601 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2025364 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1995128 |
| 108 | Amoebiasis_Homo sapiens_hsa05146 | -0.1882907 |
| 109 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1819649 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1760547 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1662114 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | -0.1610823 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1388600 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1368058 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1346524 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1289585 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1275339 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1102796 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1077277 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1046304 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0856024 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0745793 |
| 123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0490325 |

